MIS18A-AS1: A Potential Drug Target and Biomarker (G100874202)

Target Name: MIS18A-AS1

NCBI ID: G100874202

MIS18A-AS1

Other Name(s): MIS18A antisense RNA 1

MIS18A-AS1: A Potential Drug Target and Biomarker

MIS18A-AS1, also known as MIS18A-AS1 gene, is a gene that has been identified in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function and role in these diseases are not well understood yet, but research is ongoing to determine if it can be used as a drug target or biomarker.

The MIS18A-AS1 gene is located on chromosome 18 and has been shown to encode a protein that is involved in various cellular processes, including cell adhesion, migration, and invasion. The protein produced by this gene has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of MIS18A-AS1 is its role in cell adhesion and migration. This gene has been shown to be involved in the formation of tight junctions, which are essential for maintaining the integrity of tissues and are critical for various physiological processes, including cell signaling and communication. MIS18A-AS1 has also been shown to be involved in the regulation of cell division and the maintenance of stem cell properties.

In neurodegenerative diseases, MIS18A-AS1 has been shown to be involved in the development and progression of diseases, including Alzheimer's disease and Parkinson's disease. Studies have shown that MIS18A-AS1 is expressed in the brains of individuals with these conditions and that its levels are decreased in the brains of individuals with these conditions compared to healthy individuals. This suggests that MIS18A-AS1 may be a potential drug target for these diseases.

In autoimmune disorders, MIS18A-AS1 has been shown to be involved in the development and progression of these conditions. Studies have shown that MIS18A-AS1 is expressed in the tissues of individuals with autoimmune disorders and that its levels are increased in individuals with these conditions compared to healthy individuals. This suggests that MIS18A-AS1 may be a potential biomarker for autoimmune disorders.

Despite the ongoing research on MIS18A-AS1, its role in these diseases is not yet fully understood. More research is needed to determine if it can be used as a drug target or biomarker for these conditions. Additionally, further research is needed to fully understand its function and role in these diseases.

In conclusion, MIS18A-AS1 is a gene that has been identified in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function and role in these diseases are not yet fully understood, but research is ongoing to determine if it can be used as a drug target or biomarker. Further research is needed to fully understand its function and role in these diseases, and to determine if it can be used as a potential treatment for these conditions.

Protein Name: MIS18A Antisense RNA 1

The "MIS18A-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIS18A-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets